Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update on thalassemia.

P J Giardina1, M W Hilgartner

  • 1Director of Thalassemia Service, New York Hospital-Cornell University Medical College, NY.

Pediatrics in Review
|February 1, 1992
PubMed
Summary
This summary is machine-generated.

Advances in thalassemia management include genetic defect identification, prenatal diagnosis, and improved treatments like iron chelation and bone marrow transplantation. Research focuses on safer blood products and gene therapy for thalassemia.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

`An account of an hemorrhagic disposition existing in certain families'.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same author

The significance of a positive DAT in thalassemia patients.

Immunohematology·2011
Same author

Quality of life in thalassemia: a comparison of SF-36 results from the thalassemia longitudinal cohort to reported literature and the US norms.

American journal of hematology·2010
Same author

Prevalence of fractures among the Thalassemia syndromes in North America.

Bone·2005
Same author

MICA and recovery from hepatitis C virus and hepatitis B virus infections.

Genes and immunity·2004
Same author

Long-term FEIBA prophylaxis does not prevent progression of existing joint disease.

Haemophilia : the official journal of the World Federation of Hemophilia·2003

Area of Science:

  • Hematology
  • Genetics
  • Molecular Biology

Background:

  • Thalassemia syndromes encompass a group of inherited blood disorders.
  • Significant progress has been made in understanding these conditions.

Purpose of the Study:

  • To review recent advances in the understanding and management of thalassemia.
  • To highlight key developments in genetic defect identification, diagnosis, and therapeutic strategies.

Main Methods:

  • Review of recent scientific literature and clinical advancements.
  • Identification of genetic defects using molecular biology.
  • Establishment of clinical management standards.

Main Results:

  • Genetic defects causing thalassemia are now identified.

Related Experiment Videos

  • Prenatal diagnosis is feasible through molecular technology.
  • Established standards for transfusion, splenectomy, infection prevention, and iron chelation therapy.
  • Bone marrow transplantation is a viable option for eligible patients.

    • Conclusions:

    • Current research aims for safer blood products and oral iron chelators.
    • Further understanding of globin gene regulation is crucial for gene transfer therapies.
    • Comprehensive management strategies have significantly improved thalassemia care.